Adil Najdi
Sidi Mohamed Ben Abdellah University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Adil Najdi.
Preventive Medicine | 2011
Adil Najdi; Youness El Achhab; Chakib Nejjari; Teresa Norat; Ahmed Zidouh; Karima El Rhazi
PURPOSE To estimate the prevalence of physical activity (PA) and associated variables in the Moroccan adult population. METHODS Population-based, May 2008 survey of a representative sample of Moroccan adults. PA was assessed using the International Physical Activity Questionnaire (IPAQ). RESULTS Mean age was 41.4 years (26.2-56.6). Of the 2613 subjects, 48.1% were women and 58% lived in urban areas. The prevalence of the lowest physically active category was 16.5% overall, 24% in women and 9% in men (p < 0.001). Unemployed (18.6%) and retired individuals (17.9%), housewives (28.2%) and married persons (19.7%) reported lower levels of physical activity. Older age, unemployment or retirement, having high income, and being overweight or obese were the main determinants of low PA levels in men. In women, the main determinants of low PA levels were living in an urban area and being a housewife. CONCLUSION This survey has identified that urbanization and having high income are main determinants of low physical activity in Moroccan adults in a country undergoing economic transition.
International Journal of Dermatology | 2016
Mariame Meziane; Awatef Kelati; Adil Najdi; Amine Berraho; Chakib Nejjari; Fatim‐Zahra Mernissi
Several recent reports have shown a significant association between psoriasis and metabolic syndrome (MBS).
Asian Pacific Journal of Cancer Prevention | 2015
Samira El Fakir; Adil Najdi; Youssef Chami Khazraji; Maria Bennani; Latifa Belakhel; Loubna Abousselham; B. Lyoussi; Rachid Bekkali; Chakib Nejjari
BACKGROUND Breast cancer is commonly diagnosed at late stages in countries with limited resources. In Morocco, breast cancer is ranked the first female cancer (36.1%) and screening methods could reduce the proportion presenting with a late diagnosis. Morocco is currently adopting a breast cancer screening program based on clinical examination at primary health facilities, diagnosis at secondary level and treatment at tertiary level. So far, there is no systematic information on the performance of the screening program for breast cancer in Morocco. The aim of this study was to analyze early performance indicators. MATERIALS AND METHODS A retrospective evaluative study conducted in Temara city. The target population was the entire female population aged between 45-70 years. The study was based on process and performance indicators collected at the individual level from the various health structures in Tamara between 2009 and 2011. RESULTS A total of 2,350 women participated in the screening program; the participation rate was 35.7%. Of these, 76.8% (1,806) were married and 5.2% (106) of this group had a family history of breast cancer. Of the women who attended screening, 9.3% (190) were found to have an abnormal physical examination findings. A total of 260 (12.7%) were referred for a specialist consultation. The positive predictive value of clinical breast examination versus mammography was 23.0%. Forty four (35.5%) of the lesions found on the mammograms were classified as BI-RADs 3; 4 or 5 category. Cancer was found in 4 (1.95%) of the total number of screened women and benign cases represented 0.58%. CONCLUSIONS These first results of the programme are very encouraging, but there is a need to closely monitor performance and to improve programme procedures with the aim of increasing both the participation rate and the proportion of women eligible to attend screening.
Asian Pacific Journal of Cancer Prevention | 2012
Mohamed Berraho; Adil Najdi; Simone Mathoulin-Pélissier; Roger Salamon; Chakib Nejjari
BACKGROUND For cervical cancer the epidemiological profile is poorly known in Morocco and no data is available concerning the direct medical costs. The purpose of this work is to estimate the direct cost of medical management of invasive cervical cancer during the first year after diagnosis in Morocco. METHODS The estimation of direct costs of medical management of invasive cervical cancer during the first year after diagnosis in Morocco is based on the estimation of individual cost in each stage which covers diagnosis, treatment and follow-up during first year. The cost was estimated per patient and whole cycle-set using the costs for each drug and procedure as indicated by the Moroccan National Agency for Health Insurance. Extrapolation of the results to the whole country was used to calculate the total annual cost of cervical cancer treatments in Morocco. RESULTS Overall approximately 1,978 new cases of cervical cancer occur each year in Morocco. The majority (82.96%) of these cases were diagnosed at a late stage (stage II or more). The cost of one case of cervical cancer depends on stage of diagnosis, the lowest cost is
Pediatrics International | 2017
Awatef Kelati; H. Baybay; Adil Najdi; Safae Zinoune; Fatima Zahra Mernissi
382 for stage Cis followed by the cost of stage IA1 for young women (<40 years) which is
PLOS ONE | 2016
Nabil Tachfouti; Adil Najdi; Sergi Alonso; Elisa Sicuri; Abderahmane Laamrani El Idrissi; Chakib Nejjari; Albert Picado
2,952. The highest cost is for stage IV, which is
Asian Pacific Journal of Cancer Prevention | 2017
N. Abda; Adil Najdi; Samira El Fakir; Nabil Tachfouti; Mohamef Berraho; Youssef Chami Khazraji; Loubna Abousselham; Latifa Belakhel; Rachid Bekkali; Chakib Nejjari
7,827. The total cost of cervical cancer care for one year after diagnosis is estimated at
Current Rheumatology Reviews | 2016
Jamila Essouiri; Fatima Ezzahra Abourazzak; Faiza Lazrak; Adil Najdi; Nadia Benaicha; Taoufik Harzy; Mourad Errasfa
13,589,360. The share allocated to treatment is the most important part of the global care budget with an annual sum of
Saudi Journal of Kidney Diseases and Transplantation | 2015
N. Kabbali; S. Mikou; Ghita El Bardai; Adil Najdi; Meriem Ezziani; Fatima Zahra Batta; Nada Tazi El Pardiya; Chadia El Fadil; Aniss El Hassani; Mohamed Arrayhani; Tarik Sqalli Houssaini
13,027,609 whereas other cost components are represented as follows:
Saudi Journal of Kidney Diseases and Transplantation | 2015
H. Mbarki; Nada Tazi; Adil Najdi; Nabil Tachfouti; Mohamed Arrayhani; Tarik Sqalli
435,694 for annual follow-up activity and